SC
Steven Cohen (Point72) disclosed decreased in DAY ONE BIOPHARMACEUTICALS I
Steven Cohen (Point72) filed a 13F change in DAY ONE BIOPHARMACEUTICALS I (23954D109) on 2026-05-15, covering period end 2026-03-31.
Action
Decreased
Capital
$771,089 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.